B
ased on the data presented in the single-laboratory validation study (SLV) reported by Campos Giménez et al. (1) , the method "Determination of Vitamin B 12 in Infant Formulas and Adult Nutritionals by LC-UV Detection with Immunoaffinity Extraction" was granted First Action status and designated AOAC 2011.08 (2, 3) .
The original validation study included a large range of fortified products, not only infant formulas but also breakfast cereals and beverages. The data provided for infant formulas and adult/pediatric nutritionals was limited and needed to be extended to the full set of Stakeholder Panel on Infant Formula and Adult Nutritionals (SPIFAN) matrixes. The method has been further improved by introduction of rapid ultra-HPLC (UHPLC), a multilevel external calibration curve, and change of reconstitution rate and sample weight used to comply with SPIFAN requirements. Additional sample preparation for the analysis of amino acid-based products has now been included. These modifications allow full compliance with standard method performance requirements (SMPR) established for vitamin B 12 (4) in terms of LOQ (≤0.01 µg/100 g), working range (0.01-5.0 µg/100 g), repeatability (≤7%) and recovery (90-110%). The improved method was granted AOAC First Action status 2014.02.
AOAC Official Method 2014.02
Vitamin B 12 in Infant Formula and Adult/Pediatric Formulas
Ultra-High-Performance Liquid Chromatography
First Action 2014
[Applicable for the determination of vitamin B 12 in all forms of infant, adult, and/or pediatric formula (powders, ready-to-feed liquids, and liquid concentrates), made from any combination of milk, soy, rice, whey, hydrolyzed protein, starch, and amino acids, with and without intact protein.] Caution: The method uses commonly used solvents and reagents. Refer to appropriate manuals or safety data sheets to ensure that the safety guidelines are applied before using chemicals.
Cyanide.-Fatal if swallowed, inhaled, or comes in contact with skin. Wear protective gloves, clothing, and eyewear. Wash hands immediately after handling the product. Cyanide reacts with acids to form highly toxic and rapid acting HCN gas. Use only in effective fume removal device to remove vapors generated. Destroy residues with alkaline NaOCl solution.
Trifluoroacetic acid (TFA).-Causes severe burns and eye damage. Wear protective gloves, clothing, eyewear, and face protection. Use only in effective fume removal device to remove vapors generated.
See Table 2014 .02A for samples used during validation of the method. The set is composed of six nonfortified (placebo) products and 12 fortified products. It also includes a Standard Reference Material, SRM 1849a Infant/Adult Nutritional Formula, from the National Institute of Standards and Technology (Gaithersburg, MD) with a reference value for vitamin B 12 .
A. Principle
Vitamin B 12 is extracted from the sample using sodium acetate buffer in the presence of sodium cyanide at 100°C for 30 min. Extracts are purified and concentrated with an immunoaffinity column. Vitamin B 12 is determined by ultrahigh-performance liquid chromatography with UV detection at 361 nm.
B. Apparatus and Materials
(a) Balances.-With readability of 0.1 mg (AT200; Mettler-Toledo Inc., Greifensee, Switzerland) and 0.01 g (PE400; Mettler-Toledo Inc. (2, 10, 20, 40, 60 , 100 ng/mL).-Pipet into six separate 10 mL amber glass volumetric flasks, 50, 250, 500, 1000, 1500, and 2500 µL vitamin B 12 intermediate standard solution. Dilute to volume with sample dilution solvent, (e). Filter the solution through a folded paper filter. In the case of high-fat products, and if recovery is low, dilute the filtrate 1:3 in water before cleanup to improve recovery or repeat the extraction by using a smaller sample portion.
D. Preparation of Reagents and Standard Solutions

E. Sample Preparation and Extraction
(e) Immunoaffinity cleanup.-Let the immunoaffinity columns warm to room temperature by removing them from refrigeration at least 30 min before use. Place each immunoaffinity column on the rack. Open the caps and let the storage buffer drain by gravity. Close the lower cap. Load the column with 9 mL clear filtrate and close the upper cap. Place the column in a rotary shaker, and mix slowly for 10-15 min. Return the column to the support and let stand for a few minutes. Open the caps to let the liquid drain by gravity. Wash the column with 10 mL water. With a syringe, insert about 40 mL air to dry the column. Elute with 3 mL methanol, and collect eluate in a 4 or 7 mL amber glass reaction vial. Rinse the column with 0.5 mL methanol, and with a syringe, insert about 20 mL air to collect all the methanol in the same vial. Evaporate the eluate at 50°C under a stream of nitrogen. Reconstitute the sample in 0.3 mL sample dilution solvent, D(e). Mix on a Vortex mixer. Transfer to a micro amber vial.
F. Analysis
(a) Chromatographic conditions.-Flow rate, 0.4 mL/min; injection volume, 50 µL; detection, UV at 361 nm; gradient elution, see 
where A = response (height) of the peak obtained for the sample solution, I = intercept of the calibration curve, S = slope of the calibration curve, V 0 = volume of the test solution (volume used to dissolve the test portion) in mL (100 mL), V 2 = volume in which the aliquot of sample solution is reconstituted after immunoaffinity cleanup (0.3 mL), m = weight of the test portion, as reconstituted, in g (60 g), and V 1 = volume of the aliquot of sample solution loaded onto the affinity column (9 mL). For amino acid-based products calculate the vitamin B 12 content on the sample and on the blank, E(e); take into account the additional dilution factor 1/5 in the calculations. Deduct the amount of vitamin B 12 in the blank to the amount in the sample. (g) Reporting.
-Report results with two decimal points as cyanocobalamin, in µg/100 g of reconstituted product. Reconstitution rates are 25 g/225 g for powder products, 50 g/100 g for concentrates, and 1 g/1 g for ready-to-feed formulas.
Validation Protocol
(a) Linearity.-Three independent stock solutions of cyanocobalamin were prepared at a concentration of 100 µg/mL. Working solutions at different levels prepared from dilution of stock solutions were injected in triplicate.
(b) LOD/LOQ.-Ten independent analysis of a nonfortifi ed liquid sample, overdiluted to obtain a fi nal concentration of about 0.005 µg/100 g, were used for determination of LOD and LOQ as LOD = blank mean + 3 SD and LOQ = blank mean + 10 SD.
(c) Trueness.-Reference material (SRM 1849a) was analyzed in duplicate over 6 days by two different analysts. Overall mean was calculated and compared to the reference value.
(d) Recovery.-Spiking experiments were performed at 50 and 100% of typical target levels in infant formula, on three selected nonfortifi ed products. Spiked and nonspiked samples were analyzed in duplicate on 3 different days by two different analysts. The rest of the nonfortifi ed products were spiked and analyzed in duplicate on a single day. The overall mean of unspiked samples was used to compute recoveries.
(e) Precision studies.-Six fortifi ed samples, including SRM 1849a, were selected for precision studies and analyzed in duplicate on 6 different days by two analysts. Fresh reagents and working standards were prepared each day. Repeatability was verifi ed on the rest of the samples by analyzing them in duplicate on a single day; this was due to insuffi cient amount of sample available to run on multiple days.
(f) Statistics.-SD of repeatability (S r ) and SD of intermediate reproducibility (S iR ) were used as measures of within-day and between-day variability, respectively. They were calculated from the data obtained in the precision studies as:
where n is the number of duplicate determinations; x i1 and x i2 are the two single results with i going from 1 to n and SD 2 (b) is the SD between the means of duplicates. Recovery rates (%) were calculated from spiking experiments as:
where C spiked is the concentration measured in the spiked sample; C native is the concentration measured in the nonfortifi ed sample (overall mean of unspiked samples); and C added is the concentration of analyte added.
Validation Results
Chromatography.-Example chromatograms using the newly validated conditions (UHPLC) are shown in Figure 1 . Chromatographic time has been reduced from the previously reported 16 min to about 8 min.
Linearity.-An extended calibration range (from 2 to 500 ng/mL) was used for linearity demonstration (Figure 2) . Calibration curves were plotted and linearity demonstrated by R 2 > 0.9999 and calibration errors well below 5% for all levels except the lowest concentration (2 ng/mL; corresponding to lower LOQ 0.01 µg/100 g), which showed, in some cases, calibration errors 10-20%. It was considered acceptable at this low level. During routine analysis, a reduced calibration range from 2 to 100 ng/mL, which covers the range 0.01-0.55 µg/100 g, is recommended. This range can be extended as needed.
LOD/LOQ.-Due to the absence of a matrix devoid of vitamin B 12 in the SPIFAN kit to be used in establishing LOD and LOQ, a nonfortified product over-diluted to contain about 0.005 µg/100 g was used. The results from 10 independent analyses showed an average of 0.006 µg/100 g, with SD of 0.0007 µg/100 g. Thus, LOD was estimated at 0.008 µg/100 g and LOQ at 0.013 µg/100 g.
Trueness.
-Results on SRM 1849a (Infant/Adult Nutritional Formula) are shown in Table 1 . The overall mean of duplicate analysis was 0.435 µg/100 g, with SD (b) (SD of the mean of duplicates) of 0.010 µg/100 g, which is well within the reference range of 0.482 ± 0.085 µg/100 g.
Recovery.
-Results of spiking experiments are shown in Table 2 . Most recoveries obtained using the method as previously described complied with requirements (90-100%), except for the Adult Nutritional ready-to-feed (RTF) High Fat and Infant Elemental Powder, with recoveries around 80% (data not shown).
For those two samples, sample preparation was adapted to allow better recovery rates. Briefly, the Adult Nutritional RTF High Fat was diluted three times in water to reduce matrix effect before extraction; while in the case of the amino acidbased (elemental) product, a source of intact protein (skimmed milk powder) was added to mimic regular matrixes. These adaptations allowed obtaining recovery rates within acceptable ranges. After adaptation, recovery rates in all samples ranged from 87.8 to 98.3%. Mean recovery was 91.7 ± 4.0% (mean ± SD).
Precision.-Precision data are shown in Tables 1 and 3 . RSD of repeatability, S r , was below 7%, except for Infant Formula Powder (S r = 8.2%) and RSD of intermediate reproducibility, S iR , was not higher than 11%. Repeatability was confirmed on the rest of the matrixes (fortified or not) by duplicate analysis on a single day. Only the Child Formula Powder (nonfortified) showed differences between duplicates higher than 7%.
Conclusions
The adaptations provided to the method allow meeting all requirements specified in the SMPR. Response was linear in the range 2-500 ng/mL, which corresponds to 0.01-2.8 µg/100 g (as reconstituted product); this range can easily be extended by dilution of sample extracts. LOD and LOQ were 0.008 and 0.013 µg/100 g, respectively. Accuracy of the method was proven by successful analysis of a Certified Reference Material (SRM 1849a Infant/Adult Nutritional Formula), as well as by recovery rates generally within 90-110% at 50 and 100% target values for infant formulas. Precision estimations (S r and S iR ) determined in the range 0.2-1.2 µg/100 g were below 7 and 11%, respectively, for all matrixes tested (six selected products) except for Infant Formula Powder Milk Based (S r = 8.2%). a All results reported in µg/100 g of reconstituted product (reconstitution rate 25 g + 200 g water) or ready-to-feed. Mean of duplicate analysis performed by two different analysts on 6 different days. SD (b) = SD of mean of duplicates; S r = SD of repeatability; CV r = RSD of repeatability; S iR = SD of intermediate reproducibility; CV iR = RSD of intermediate reproducibility. The method was found suitable for the determination of vitamin B 12 , in the form of cyanocobalamin, as well as the naturally occurring forms (mainly hydroxyl-, adenosyl-, and methylcobalamin) in infant formula and adult/pediatric formula. a n = Number of days. Levels 1 and 2 are 0.15 and 0.30 µg/100 g for all products except infant elemental powder, for which level 1 is 2.25 µg/100 g and Level 2 is 4.50 µg/100 g. Native content is reported in µg/100 g of reconstituted or RTF product (reconstitution rate 25 g + 225 g water). 
